Themis Medicare (NSE:THEMISMED) ROCE % : 18.24% (As of Sep. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Themis Medicare ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Themis Medicare's annualized ROCE % for the quarter that ended in Sep. 2024 was 18.24%.

Themis Medicare ROCE % Historical Data

The historical data trend for Themis Medicare's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Themis Medicare ROCE % Chart

Themis Medicare Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

20.93

23.88

36.29

23.23

15.53

Themis Medicare Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															16.03	10.92	8.90	32.74	18.24

Themis Medicare ROCE % Calculation

Themis Medicare's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	610.707	/	( ( (5139.561 - 1391.285)	+	(5664.165 - 1545.846) )	/ 2 )
	=	610.707	/	( (3748.276	+	4118.319)	/ 2 )
	=	610.707	/	3933.2975
	=	15.53 %

Themis Medicare's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	809.512	/	( ( (0 - 0)	+	(6022.144 - 1584.148) )	/ 1 )
	=	809.512	/	( ( 0	+	4437.996 )	/ 1 )
	=	809.512	/	4437.996
	=	18.24 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Themis Medicare (NSE:THEMISMED) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Themis Medicare ROCE % Related Terms

Thank you for viewing the detailed overview of Themis Medicare's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Themis Medicare Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Themis Medicare Ltd (NSE:THEMISMED) » Definitions » ROCE %

Traded in Other Exchanges

530199:India

Address

Swami Vivekanand Road, 11/12, Udyog Nagar Industrial Estate, Goregaon (West), Mumbai, MH, IND, 400 104

Website

https://www.themismedicare.com

Themis Medicare Ltd is an Indian based company engaged in the manufacturing and marketing of pharmaceutical products. The Company operates only in one business segment which is Pharmaceuticals. Geographically, it derives a majority of revenue from India and also has a presence in the international market. Its product categories include Anti Malarial, CCD products, Nutritional Gummies, and Candy and Other Products such as OD-LM, Dexem, Medzol and Tazowin.

Themis Medicare Headlines

No Headlines